Literature DB >> 30165987

Exercise Training for Patients With Hypertrophic Cardiomyopathy: JACC Review Topic of the Week.

Katrin A Dias1, Mark S Link2, Benjamin D Levine3.   

Abstract

Current guidelines recommend that patients with hypertrophic cardiomyopathy (HCM) not partake in high-intensity exercise due to the increased risk of sudden cardiac death. But individuals with genetic cardiomyopathies are not immune from cardiometabolic diseases, and inactivity is common in patients with HCM, likely due to fear of exercise-induced adverse events. The RESET-HCM trial (Study of Exercise Training in Hypertrophic Cardiomyopathy) illustrated that although moderate-intensity exercise may be safe in this population, the increase in cardiorespiratory fitness achieved with this training paradigm is modest. High-intensity exercise is an efficacious stimulus for increasing cardiorespiratory fitness in chronic disease populations. Such increases in fitness are associated with substantial reductions in cardiovascular mortality and may outweigh the theoretical risks associated with exercise in patients with HCM. The goal of this review is to examine the evidence supporting the safety and efficacy of different intensities of exercise training in HCM, and consider novel strategies to improve fitness.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  arrhythmia; cardiorespiratory fitness; exercise guidelines; high-intensity training; sudden cardiac death

Mesh:

Year:  2018        PMID: 30165987     DOI: 10.1016/j.jacc.2018.06.054

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

Review 1.  The prevention and management of sudden cardiac arrest in athletes.

Authors:  Yehia Fanous; Paul Dorian
Journal:  CMAJ       Date:  2019-07-15       Impact factor: 8.262

2.  Hypertrophic cardiomyopathy and exercise: a need for more information.

Authors:  Michael J Joyner
Journal:  J Physiol       Date:  2019-02-03       Impact factor: 5.182

3.  Exercise Recommendations in Pediatric HCM: Variation and Influence of Provider Characteristics.

Authors:  Robert D Whitehill; Seshadri Balaji; Michael Kelleman; Stephanie F Chandler; Dominic J Abrams; Chad Mao; Peter Fischbach; Robert Campbell
Journal:  Pediatr Cardiol       Date:  2021-08-18       Impact factor: 1.655

Review 4.  Hypertrophic cardiomyopathy.

Authors:  Murillo de Oliveira Antunes; Thiago Luis Scudeler
Journal:  Int J Cardiol Heart Vasc       Date:  2020-03-25

5.  Exercise and myocardial injury in hypertrophic cardiomyopathy.

Authors:  G Etienne Cramer; D H Frank Gommans; Hendrik-Jan Dieker; Michelle Michels; Freek Verheugt; Menko-Jan de Boer; Jeannette Bakker; Michael A Fouraux; Janneke Timmermans; Marcel Kofflard; Marc Brouwer
Journal:  Heart       Date:  2020-01-30       Impact factor: 5.994

Review 6.  Cardiopulmonary Exercise Test in Patients with Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis.

Authors:  Adrián Bayonas-Ruiz; Francisca M Muñoz-Franco; Vicente Ferrer; Carlos Pérez-Caballero; María Sabater-Molina; María Teresa Tomé-Esteban; Bárbara Bonacasa
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

Review 7.  Hypertrophic Cardiomyopathy: Updates Through the Lens of Sports Cardiology.

Authors:  Bradley S Lander; Dermot M Phelan; Matthew W Martinez; Elizabeth H Dineen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-05-25

Review 8.  Unraveling the Genotype-Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity-Related Cardiac Defects as a Major Disease Modifier.

Authors:  Edgar E Nollet; B Daan Westenbrink; Rudolf A de Boer; Diederik W D Kuster; Jolanda van der Velden
Journal:  J Am Heart Assoc       Date:  2020-11-11       Impact factor: 6.106

Review 9.  Shock to the Heart: Psychosocial Implications and Applications of Sudden Cardiac Death in the Young.

Authors:  Nicholas Grubic; Jake Puskas; Dermot Phelan; Anne Fournier; Luc J Martin; Amer M Johri
Journal:  Curr Cardiol Rep       Date:  2020-10-10       Impact factor: 3.955

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.